Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats

Journal of Urology

Volumn 172, Issue 4 I, 2004, Pages 1529-1532

  Chuang, Yao Chi ^a   Yoshimura, Naoki ^b   Huang, Chao Cheng ^a   Chiang, Po Hui ^a   Chancellor, Michael B ^b,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Kaufmann Building ^*  (United States)

Author keywords

Bladder; Botulinum toxin type A; Cystitis, interstitial; Pain; Urodynamics

Indexed keywords

ACETIC ACID; BOTULINUM TOXIN A; PROTAMINE SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER DISEASE; CATHETERIZATION; CONTROLLED STUDY; CYSTALGIA; CYSTOMETRY; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

EID: 4544372009     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000137844.77524.97     Document Type: Article

References (21)

1. Parsons, C. L., Lilly, J. D. and Stein, P.: Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol, 145: 732, 1991
2. Parsons, C. L., Housley, T., Schmidt, J. D. and Lebow, D.: Treatment of interstitial cystitis with intravesical heparin. Br J Urol, 73: 504, 1994
3. Chuang, Y.-C., Fraser, M. O., Yu, Y., Chancellor, M. B., de Groat, W. C. and Yoshimura, N.: The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol, 165: 975, 2001
4. Hohenfellner, M., Nunes, L., Schmidt, R. A., Lampel, A., Thuroff, J. W. and Tanagho, E.: Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J Urol, 147: 587, 1992
5. Grazko, M. A., Polo, K. B. and Jabbari, B.: Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology, 45: 712, 1995
6. Jankovic, J., Schwartz, K. and Donovan, D. T.: Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry, 53: 633, 1990
7. Welch, M. J., Purkiss, J. R. and Foster, K. A.: Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum. neurotoxins. Toxicon, 38: 245, 2000
8. Purkiss, J. R., Welch, M. J., Doward, S., Foster, K. A. and Quinn, C. P.: A method for the measurement of [3H]-glutamate release from cultured dorsal root ganglion neurons. Biochem Soc Trans, 26: S108, 1998
9. Argoff, C. E.: A focused review on the use of botulinum. toxins for neuropathic pain. Clinic J Pain, 18: S177, 2002
10. Su, H. C., Wharton, J., Polak, J. M., Mulderry, P. K., Ghatei, M. A., Gibson, S. J. et al: Calcitonin gene-related peptide I immunoreactivity in afferent neurons supplying the urinary tract: combined retrograde tracing and immunohistochemistry. Neuroscience, 18: 727, 1986
11. Morrison, J.: The activation of bladder wall afferent nerves. Exp Physiol, 84: 131, 1999
12. Gabella, G. and Davis, C.: Distribution of afferent axons in the bladder of rats. J Neurocytol, 27: 141, 1998
13. Fraser, M. O., Chuang, Y. C., Tyagi, P., Yokoyama, T., Yoshimura, N., Huang, L. et al: Intravesical liposome administration-a novel treatment for hyperactive bladder in the rat. Urology, 61: 656, 2003
14. Birder, L. A. and deGroat, W. C.: Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat. J Neurosci, 12: 4878, 1992
15. Chuang, Y. C., Smith, C. P., Somogyi, G. T. and Chancellor, M. B.: Botulinum. toxin treatment of urethral and bladder dysfunction. J Formos Med Assoc, 102: 5, 2003
16. Cui, M., Khanijou, S., Rubino, J. and Aoki, K. R.: Subcutaneous administration of botulinum. toxin A reduces formalin-induced pain. Pain, 107: 125, 2004
17. Jabbari, B., Maher, N. and Difazio, M. P.: Botulinum toxin A improved burning pain and allodynia in two patients with spinal cord pathology. Pain Med, 4: 206, 2003
18. Freund, B. and Schwata, M.: Subcutaneous BTX-A in the treatment of neurogenic pain: a pilot study. Presented at 38th Integragency Botulinum Research Coordinating Committee meeting, Easton, Maryland, October 17-19, 2001
19. Stein, P. C., Pham, H., Ito, T. and Parsons, C. L.: Bladder injury model induced in rats by exposure to protamine sulfate followed by bacterial endotoxin. J Urol, 155: 1133, 1996
20. Doggweiler, R., Jasmin, L. and Schmidt, R. A.: Neurogenically mediated cystitis in rats: an animal model. J Urol, 160: 1551, 1998
21. Smith, C. P. and Chancellor, M. B.: Emerging role of botulinum. toxin in the management of voiding dysfunction. J Urol, 171: 2128, 2004